| RS1589842816 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS1589844592 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1589844927 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1589845386 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS1589846743 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1589866171 |
NFKB2
|
Health Risk |
Pathogenic |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS1589878956 |
ECHS1
|
Health Risk |
Likely pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS1589880497 |
ECHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS1589884185 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1589891039 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1589892417 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1589899290 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS1589907586 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1589908300 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS1589919815 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1589931156 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1589947644 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1589948943 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS1589950125 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS1589956565 |
KCNQ1
|
Health Risk |
Pathogenic |
— |
| RS1589957233 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Congenital long QT syndrome |
| RS1589957697 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1589957719 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1589957756 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1589962586 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS1589965249 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1589966038 |
SYCE1
|
Health Risk |
Pathogenic |
— |
| RS1589967006 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1589968661 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome |
| RS1589970134 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Medulloblastoma |
| RS1589970228 |
SUFU
|
Health Risk |
Likely pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS1589974610 |
EBF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, ataxia |
| RS1589974634 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS1589981178 |
SLC18A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormal dense granules, Abnormal dense granule content |
| RS1589994032 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1589996458 |
TUB
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy and obesity, Retinal dystrophy and obesity |
| RS1590003601 |
VPS13A
|
Health Risk |
Pathogenic/Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1590007244 |
UROS
|
Health Risk |
Pathogenic |
Cutaneous porphyria, Cutaneous porphyria |
| RS1590008294 |
DEAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1590013404 |
DEAF1
|
Health Risk |
Likely pathogenic |
— |
| RS1590017652 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-epilepsy-extrapyramidal syndrome, Developmental disorder |
| RS1590017658 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1590018153 |
TWNK
|
Health Risk |
Likely pathogenic |
mitochondrial hepatopathy, mitochondrial hepatopathy |
| RS1590020406 |
TWNK
|
Health Risk |
Pathogenic |
— |
| RS1590020571 |
TWNK
|
Health Risk |
Likely pathogenic |
Infantile onset spinocerebellar ataxia, Infantile onset spinocerebellar ataxia |
| RS1590028691 |
DEAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1590039859 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS1590045340 |
PDZD7
|
Health Risk |
Likely pathogenic |
— |
| RS1590054876 |
DNA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA deletion syndrome with progressive myopathy, Mitochondrial DNA deletion syndrome with progressive myopathy |
| RS1590055107 |
DNA2
|
Health Risk |
Likely pathogenic |
— |
| RS1590059865 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS1590061914 |
SUFU
|
Health Risk |
Pathogenic |
— |
| RS1590062006 |
SUFU
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS1590062007 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1590062899 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS1590062961 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1590063305 |
SUFU
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS1590065940 |
SUFU
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1590066162 |
SUFU
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1590072094 |
TALDO1
|
Health Risk |
Likely pathogenic |
— |
| RS1590076969 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4B2 |
| RS1590081328 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital long QT syndrome, Long QT syndrome |
| RS1590081349 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1590081467 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Congenital long QT syndrome |
| RS1590082242 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1590082264 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS1590082278 |
SUFU
|
Health Risk |
Pathogenic |
— |
| RS1590084324 |
SUFU
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1590088831 |
KCNC1
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy type 7, Progressive myoclonic epilepsy type 7 |
| RS1590092132 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1590102028 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1590106815 |
KCNC1
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy type 7, Progressive myoclonic epilepsy type 7 |
| RS1590122229 |
ARL3
|
Health Risk |
Pathogenic |
Progressive cone degeneration, Progressive cone degeneration |
| RS1590126497 |
ENTPD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 64, Hereditary spastic paraplegia 64 |
| RS1590129146 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1590129294 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1590129454 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1590129487 |
XRCC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1590134297 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS1590140903 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1590150660 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1590154255 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS1590165106 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1590166832 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1590168246 |
TH
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Autosomal recessive DOPA responsive dystonia |
| RS1590168368 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1590169700 |
SLC6A5
|
Health Risk |
Pathogenic |
Exaggerated startle response, Exaggerated startle response |
| RS1590169710 |
TH
|
Health Risk |
Pathogenic |
Dystonic disorder, Autosomal recessive DOPA responsive dystonia |
| RS1590169802 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1590170978 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1590174665 |
SLC6A5
|
Health Risk |
Likely pathogenic |
SLC6A5-related disorder, SLC6A5-related disorder |
| RS1590192032 |
ABCC2
|
Health Risk |
Pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS1590203064 |
CYP17A1
|
Health Risk |
Pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |
| RS1590203882 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS1590204913 |
CYP17A1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |
| RS1590215915 |
PGAP2
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 3, Hyperphosphatasia with intellectual disability syndrome 3 |
| RS1590216677 |
LDHA
|
Health Risk |
Pathogenic |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS1590230520 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1590239797 |
SBF2
|
Health Risk |
Likely pathogenic |
— |
| RS1590243044 |
CNNM2
|
Health Risk |
Likely pathogenic |
— |